Quick Answer
BriaCell Therapeutics Corp. reported Net Income of -$26.31 million for fiscal year 2025.
BriaCell Therapeutics Corp. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$26.31M | -449.1% |
| 2024 | -$4.79M | +76.4% |
| 2023 | -$20.30M | +24.4% |
| 2022 | -$26.84M | -94.3% |
| 2021 | -$13.82M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| October 31, 2025 | -$8.20M | -41.3% | -33.8% |
| April 30, 2025 | -$6.13M | -457.1% | +2.6% |
| January 31, 2025 | -$6.29M | +44.3% | -8.4% |
| October 31, 2024 | -$5.80M | -196.7% | -438.2% |
| April 30, 2024 | $1.72M | +135.0% | +115.2% |
| January 31, 2024 | -$11.29M | +4.9% | -288.2% |
| October 31, 2023 | $6.00M | +642.4% | +222.6% |
| April 30, 2023 | -$4.90M | +51.1% | +58.8% |
- BriaCell Therapeutics Corp. showed a decrease of -449.1% in Net Income compared to the prior fiscal year.
- Over the 2021–2025 period, BriaCell Therapeutics Corp.’s net income has declined by 90.4% (from -$13.82 million to -$26.31 million).
- The most recent figure is from BriaCell Therapeutics Corp.’s fiscal year 2025 report (Form 10-K), filed with the SEC on October 16, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: